ClinicalTrials.govpublic full text
Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders
neural tube defects, anemia, leukemia, myeloid, bone marrow transplant failure, myelodysplastic syndromes (mds), myeloproliferative disorders, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1009945
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.